Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine local infiltration formulations versus sufentanil analgesic pump after arthroscopic ACL reconstruction
ChiCTR2300070305Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Apr 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ropivacaine and sufentanil in acute postoperative pain (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Resting visual analog score and Active visual analog score. Started Apr 2023; status: recruiting.
02
Drugs
ropivacainesufentanil
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on ChiCTR2300070305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070305.